Clinical Trials Logo

Cerebrovascular Disorders clinical trials

View clinical trials related to Cerebrovascular Disorders.

Filter by:

NCT ID: NCT03239847 Completed - Clinical trials for Cerebrovascular Disorders

Cost Effectiveness of the EndoPhys Pressure Sensing Access System vs. Radial A-line for Intra-operative Blood Pressure Monitoring

Start date: September 6, 2016
Phase: N/A
Study type: Interventional

This study aims to compare the time difference between radial arterial line placement and use of the EndoPhys sheath, as well as, assess the cost effectiveness of the EnoPhys sheath vs. use of a radial arterial line based on device and operating room costs.

NCT ID: NCT03209258 Completed - Stroke Clinical Trials

The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial

INTERACT3
Start date: December 12, 2017
Phase: N/A
Study type: Interventional

Continued uncertainty exists over benefits of early intensive blood pressure (BP) lowering in acute intracerebral hemorrhage (ICH), related to the non-significant primary outcomes, patient selection, and discordant results of INTERACT2 and ATACH-II. We designed INTERACT3 to determine the effectiveness of a goal-directed care bundle of active management (intensive BP lowering, glycemic control, treatment of pyrexia and reversal of anticoagulation) vs. usual care in ICH. INTERACT3 is a large-scale pragmatic clinical trial to provide reliable evidence over the effectiveness of a widely applicable goal-directed care bundle in acute ICH.

NCT ID: NCT03171077 Completed - Stroke Clinical Trials

Virtual Rehabilitation and PNF in the Recovery of the Motor Function Post Stroke

Start date: June 10, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effects of use the Nintendo Wii® (NW) and therapeutic exercises by the method Proprioceptive Neuromuscular Facilitation (PNF) in the recovery of the motor function of poststroke hemiparesis patients.

NCT ID: NCT03153150 Completed - Atrial Fibrillation Clinical Trials

Start or STop Anticoagulants Randomised Trial (SoSTART)

SoSTART
Start date: March 28, 2018
Phase: Phase 3
Study type: Interventional

Primary research question: For adults surviving spontaneous (non-traumatic) symptomatic intracranial haemorrhage with persistent/paroxysmal atrial fibrillation/flutter (AF), does starting full treatment dose oral anticoagulation (OAC) result in a beneficial net reduction of all serious vascular events compared with not starting OAC? Trial design: Investigator-led, multicentre, randomised, open, assessor-masked, parallel group, clinical trial of investigational medicinal product (CTIMP) prescribing strategies. Investigators plan for a pilot phase, followed by a safety phase.

NCT ID: NCT03043092 Completed - Clinical trials for Cerebral Vascular Disorder

Transcranial Doppler Ultrasound in Critically Ill Patients With Cardiovascular Comorbidities

CRITIDOP
Start date: June 14, 2016
Phase:
Study type: Observational

Transcranial Doppler ultrasound is bedside tool use to assess cerebral blood perfusion in critically ill patients. We sought to conduct a prospective, single centre study aiming to determine whether chronic vascular diseases may be a confounder in transcranial Doppler ultrasound assessment in critically ill patients.

NCT ID: NCT03037255 Completed - Diabetes Mellitus Clinical Trials

Association of Long-term Conditions With Survival Following Heart Attack in England and Wales

Start date: January 2003
Phase:
Study type: Observational [Patient Registry]

This study aims to determine the extent to which pre-existing long-term conditions are associated with survival following a heart attack (acute myocardial infarction) using observational data from the UK's national heart attack register.

NCT ID: NCT03020433 Completed - Stroke Clinical Trials

Novel Brain Stimulation Therapies in Stroke Guided Expressions of Plasticity

Start date: March 2016
Phase: Early Phase 1
Study type: Interventional

The investigators ultimate goal is to personalize brain stimulation for stroke so outcomes of the upper limb can be maximized for each individual patient. Several groups including the investigators have recently theorized that personalizing stimulation so as to selectively stimulate iM1 in mild, and cPMd in patients with greater severity would help generalize benefits of stimulation. The investigator premise that variances in expressions of plasticity can explain how to best stratify patients for robust, personalized stimulation.

NCT ID: NCT02966418 Completed - Clinical trials for Carotid Artery Stenosis

Hypoxic Preconditioning on Patients

Start date: January 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to study the effects of intermittent whole-body hypoxic preconditioning on patients with carotid artery stenosis.

NCT ID: NCT02920125 Completed - Clinical trials for Coronary Artery Disease

Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.

SHARP
Start date: January 2016
Phase: Phase 3
Study type: Interventional

To evaluate the benefits of Ayurvedic SUVED & REIMMUGEN Colostrum for reduction/reversal of symptoms and study clinical progress in Vascular disease; CAD, CAV, Stroke, DVT patients.

NCT ID: NCT02878707 Completed - Brain Tumor Clinical Trials

The Neuroprotective Effects of Dexmedetomidine During Brain Surgery

Start date: April 24, 2017
Phase: N/A
Study type: Interventional

Dexmedetomidine (DEX) is a Alpha-2 specific agonist, is a common ICU sedation medication. In brain tumor resection craniotomy, it is proven to be effective in improving postoperative hypertension and tachycardia, mitigates postoperative nausea and vomiting and relives postoperative pain. In addition, many animal experiments show that DEX inhibits the proapoptosis in the mitochondrial in vivo and therefore avoids neuronal injury. It is also reported to be neuroprotective to isoflurane-induced neurotoxicity and to improve cerebral focal ischemic region (penumbra). However, the neuroprotective effects were never investigated clinically in patients undergoing brain tumor resection surgery.